1. Department of GI Medical Oncology ALPHABET SOUP: MAKING SENSE OF KRAS, BRAF, RAS AND OTHER BIOMARKERS IN METASTATIC COLORECTAL CANCER Cathy Eng, M.D., F.A.C.P. Associate…
KRAS status and efficacy in the first-line treatment of patients with mCRC treated with FOLFOX with or without cetuximab: The OPUS experience Carsten Bokemeyer* I Bondarenko,…
KRAS status and efficacy in the first-line treatment of patients with mCRC treated with FOLFOX with or without cetuximab: The OPUS experience Carsten Bokemeyer* I Bondarenko,…
Slide 1 www.OncologyEducation.ca KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without…